Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers

Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers

Aim: To evaluate the impact of prescription, cost, and switching policy on the rate of switching from reference products to biosimilars. Methods: Analysis of an administrative database for prescription in a rheumatology division. Biosimilars for adalimumab and etanercept were available in 2019. Blin...

Full description

Saved in:
Bibliographic Details
Main Authors: Fernando Perez-Ruiz, Elena Garmendia-Sanchez, Javier Arostegui-Lavilla, Javier Duruelo-Echevarrieta, Joana Atxotegi-Saenz de Buruaga, Mayra Nathali Rivas-Zavaleta, Javier Casas-Arrate, Maria del Consuelo Modesto-Caballero, Amaya de Basagoiti-Gorordo
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2024-09-01
Series:Exploration of Musculoskeletal Diseases
Subjects:
biologics
biosimilars
interchangeability
switching
cost
Online Access:https://www.explorationpub.com/uploads/Article/A100764/100764.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.explorationpub.com/uploads/Article/A100764/100764.pdf

Similar Items